Ask about FDA oncology approvals, clinical trials, and treatment guidelines. Launch Oncology AI Chat Published: June 4, 2025Category: Lung Cancer Research Introduction to Neoadjuvant Nivolumab Plus Chemotherapy in CheckMate 816 The CheckMate 816 trial offers new findings on treating resectable lung cancer with neoadjuvant nivolumab plus chemotherapy. For example, it was presented at ASCO 2025 … Continue reading Neoadjuvant Nivolumab Plus Chemotherapy in Lung Cancer: CheckMate 816 Update at ASCO 2025